Skip to main content
padlock icon - secure page this page is secure

Copy Number Variation Analysis Based on Gold Magnetic Nanoparticles and Fluorescence Multiplex Ligation-Dependent Probe Amplification

Buy Article:

$106.51 + tax (Refund Policy)

A novel strategy for determining relative copy number of target genes was developed in this study based on gold magnetic nanoparticles (GMNPs) and fluorescence multiplex ligation-dependent probe amplification (fMLPA) assay. This method relies on the following stages: (1) amplification of target and reference genes by fMLPA, (2) magnetic capture of fMLPA products on GMNPs, (3) detection of the nanocomplexes by fluorescence scanner, (4) relative quantification of target gene, (5) calculation of relative copy number. The trisomy 21-related Decoy Receptor 3 (DSCR3) gene and reference glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene were selected for testing this technique. Under optimized parameters, results from 40 clinical samples showed equivalent relative copy numbers compared to theoretical values. This promising approach is simple, sensitive, selective and with low fluorescent background, thus making it suitable for copy number variation (CNV) analysis, with potential for diagnosis of genetic diseases.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: COPY NUMBER VARIATION; DSCR3; FLUORESCENCE; GOLD MAGNETIC NANOPARTICLES; MLPA; TRISOMY 21

Document Type: Research Article

Publication date: June 1, 2017

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more